Comparative genomic evidence for the involvement of schizophrenia risk genes in antipsychotic effects
Molecular Psychiatry2017Vol. 23(3), pp. 708–712
Citations Over TimeTop 10% of 2017 papers
Y Kim, Paola Giusti‐Rodríguez, James J. Crowley, Julien Bryois, Randal J. Nonneman, Allison Ryan, Corey R. Quackenbush, Maria D. Iglesias-Ussel, P H Lee, Wu‐Yi Sun, F P-M de Villena, Patrick F. Sullivan
Related Papers
- The ratios of serotonin2 and dopamine2 affinities differentiate atypical and typical antipsychotic drugs.(1989)
- → Does treatment of schizophrenia with antipsychotic medications eliminate or reduce psychosis? A 20-year multi-follow-up study(2014)116 cited
- → Increasing D2 affinity results in the loss of clozapineʼs atypical antipsychotic action(2002)32 cited
- → Neuroleptic monitoring: relation between antipsychotic efficiency and radioreceptor assay of serum haloperidol(1996)5 cited